Cargando…

Specific immune status in Parkinson’s disease at different ages of onset

Recent evidence suggests that innate and adaptive immunity play a crucial role in Parkinson’s disease (PD). However, studies regarding specific immune cell classification in the peripheral blood in PD remain lacking. Therefore, we aimed to explore the different immune status in patients with PD at d...

Descripción completa

Detalles Bibliográficos
Autores principales: Tian, Jun, Dai, Shao-Bing, Jiang, Si-Si, Yang, Wen-Yi, Yan, Yi-Qun, Lin, Zhi-Hao, Dong, Jia-Xian, Liu, Yi, Zheng, Ran, Chen, Ying, Zhang, Bao-Rong, Pu, Jia-Li
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8748464/
https://www.ncbi.nlm.nih.gov/pubmed/35013369
http://dx.doi.org/10.1038/s41531-021-00271-x
_version_ 1784631019140284416
author Tian, Jun
Dai, Shao-Bing
Jiang, Si-Si
Yang, Wen-Yi
Yan, Yi-Qun
Lin, Zhi-Hao
Dong, Jia-Xian
Liu, Yi
Zheng, Ran
Chen, Ying
Zhang, Bao-Rong
Pu, Jia-Li
author_facet Tian, Jun
Dai, Shao-Bing
Jiang, Si-Si
Yang, Wen-Yi
Yan, Yi-Qun
Lin, Zhi-Hao
Dong, Jia-Xian
Liu, Yi
Zheng, Ran
Chen, Ying
Zhang, Bao-Rong
Pu, Jia-Li
author_sort Tian, Jun
collection PubMed
description Recent evidence suggests that innate and adaptive immunity play a crucial role in Parkinson’s disease (PD). However, studies regarding specific immune cell classification in the peripheral blood in PD remain lacking. Therefore, we aimed to explore the different immune status in patients with PD at different ages of onset. We included 22 patients; among them were 10 who had early-onset PD (EOPD) and 12 had late-onset PD (LOPD) and 10 young healthy controls (YHCs) and 8 elder HCs (EHCs). Mass cytometry staining technology was used to perform accurate immunotyping of cell populations in the peripheral blood. Motor symptoms and cognitive function were assessed using the Unified Parkinson’s Disease Rating Scale (UPDRS) III score and Mini-mental State Examination (MMSE) score, respectively. T test and ANOVA statistical analysis were performed on the frequency of annotated cell population. Linear regression model was used to analyze the correlation between clusters and clinical symptoms. We characterized 60 cell clusters and discovered that the immune signature of PD consists of cluster changes, including decreased effector CD8(+) T cells, lower cytotoxicity natural killer (NK) cells and increased activated monocytes in PD patients. In summary, we found that CD8(+) T cells, NK cells, and monocytes were associated with PD. Furthermore, there may be some differences in the immune status of patients with EOPD and LOPD, suggesting differences in the pathogenesis between these groups.
format Online
Article
Text
id pubmed-8748464
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Nature Publishing Group UK
record_format MEDLINE/PubMed
spelling pubmed-87484642022-01-20 Specific immune status in Parkinson’s disease at different ages of onset Tian, Jun Dai, Shao-Bing Jiang, Si-Si Yang, Wen-Yi Yan, Yi-Qun Lin, Zhi-Hao Dong, Jia-Xian Liu, Yi Zheng, Ran Chen, Ying Zhang, Bao-Rong Pu, Jia-Li NPJ Parkinsons Dis Article Recent evidence suggests that innate and adaptive immunity play a crucial role in Parkinson’s disease (PD). However, studies regarding specific immune cell classification in the peripheral blood in PD remain lacking. Therefore, we aimed to explore the different immune status in patients with PD at different ages of onset. We included 22 patients; among them were 10 who had early-onset PD (EOPD) and 12 had late-onset PD (LOPD) and 10 young healthy controls (YHCs) and 8 elder HCs (EHCs). Mass cytometry staining technology was used to perform accurate immunotyping of cell populations in the peripheral blood. Motor symptoms and cognitive function were assessed using the Unified Parkinson’s Disease Rating Scale (UPDRS) III score and Mini-mental State Examination (MMSE) score, respectively. T test and ANOVA statistical analysis were performed on the frequency of annotated cell population. Linear regression model was used to analyze the correlation between clusters and clinical symptoms. We characterized 60 cell clusters and discovered that the immune signature of PD consists of cluster changes, including decreased effector CD8(+) T cells, lower cytotoxicity natural killer (NK) cells and increased activated monocytes in PD patients. In summary, we found that CD8(+) T cells, NK cells, and monocytes were associated with PD. Furthermore, there may be some differences in the immune status of patients with EOPD and LOPD, suggesting differences in the pathogenesis between these groups. Nature Publishing Group UK 2022-01-10 /pmc/articles/PMC8748464/ /pubmed/35013369 http://dx.doi.org/10.1038/s41531-021-00271-x Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) .
spellingShingle Article
Tian, Jun
Dai, Shao-Bing
Jiang, Si-Si
Yang, Wen-Yi
Yan, Yi-Qun
Lin, Zhi-Hao
Dong, Jia-Xian
Liu, Yi
Zheng, Ran
Chen, Ying
Zhang, Bao-Rong
Pu, Jia-Li
Specific immune status in Parkinson’s disease at different ages of onset
title Specific immune status in Parkinson’s disease at different ages of onset
title_full Specific immune status in Parkinson’s disease at different ages of onset
title_fullStr Specific immune status in Parkinson’s disease at different ages of onset
title_full_unstemmed Specific immune status in Parkinson’s disease at different ages of onset
title_short Specific immune status in Parkinson’s disease at different ages of onset
title_sort specific immune status in parkinson’s disease at different ages of onset
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8748464/
https://www.ncbi.nlm.nih.gov/pubmed/35013369
http://dx.doi.org/10.1038/s41531-021-00271-x
work_keys_str_mv AT tianjun specificimmunestatusinparkinsonsdiseaseatdifferentagesofonset
AT daishaobing specificimmunestatusinparkinsonsdiseaseatdifferentagesofonset
AT jiangsisi specificimmunestatusinparkinsonsdiseaseatdifferentagesofonset
AT yangwenyi specificimmunestatusinparkinsonsdiseaseatdifferentagesofonset
AT yanyiqun specificimmunestatusinparkinsonsdiseaseatdifferentagesofonset
AT linzhihao specificimmunestatusinparkinsonsdiseaseatdifferentagesofonset
AT dongjiaxian specificimmunestatusinparkinsonsdiseaseatdifferentagesofonset
AT liuyi specificimmunestatusinparkinsonsdiseaseatdifferentagesofonset
AT zhengran specificimmunestatusinparkinsonsdiseaseatdifferentagesofonset
AT chenying specificimmunestatusinparkinsonsdiseaseatdifferentagesofonset
AT zhangbaorong specificimmunestatusinparkinsonsdiseaseatdifferentagesofonset
AT pujiali specificimmunestatusinparkinsonsdiseaseatdifferentagesofonset